Immix Biopharma, Inc.: Form 10-Q/A for the period ended Mar 31, 2025
Filed with the SEC on May 19, 2025 and accepted by EDGAR at May 19, 2025, 17:23 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001641172-25-011519. Last ingested by Listed: Oct 27, 2026, 17:28 ET. Listed shows no prices and gives no investment advice.